"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Descriptor ID |
D000959
|
MeSH Number(s) |
D27.505.954.411.162
|
Concept/Terms |
Antihypertensive Agents- Antihypertensive Agents
- Agents, Antihypertensive
- Antihypertensives
- Anti-Hypertensives
- Anti Hypertensives
- Antihypertensive Drugs
- Drugs, Antihypertensive
- Anti-Hypertensive Agents
- Agents, Anti-Hypertensive
- Anti Hypertensive Agents
- Anti-Hypertensive Drugs
- Anti Hypertensive Drugs
- Drugs, Anti-Hypertensive
|
Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".
This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2002 | 2 | 0 | 2 |
2003 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 1 | 0 | 1 |
2006 | 2 | 1 | 3 |
2007 | 3 | 2 | 5 |
2008 | 1 | 1 | 2 |
2009 | 3 | 3 | 6 |
2010 | 1 | 0 | 1 |
2011 | 3 | 2 | 5 |
2012 | 1 | 0 | 1 |
2013 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 0 | 2 | 2 |
2020 | 1 | 2 | 3 |
2022 | 1 | 2 | 3 |
2023 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.
-
Adherence to the 2017 Clinical Practice Guidelines for Pediatric Hypertension in Safety-Net Clinics. JAMA Netw Open. 2023 04 03; 6(4):e237043.
-
Association of Preterm Birth With Prevalent and Incident Hypertension, Early-Onset Hypertension, and Cardiovascular Disease in the Women's Health Initiative. Am J Cardiol. 2023 04 01; 192:132-138.
-
The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials. Menopause. 2023 01 01; 30(1):28-36.
-
Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19. Crit Care Med. 2022 10 01; 50(10):e744-e758.
-
Do antihypertensive medications effect the mandibular cortical bone thickness? A study using cone beam computed tomography images. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022 12; 134(6):687-694.
-
Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022 05 12; 386(19):1781-1792.
-
Firibastat: An Oral First-in-Class Brain Aminopeptidase A Inhibitor for Systemic Hypertension. Cardiol Rev. 2022 Jan-Feb 01; 30(1):50-55.
-
Netarsudil for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Literature Review. Ann Pharmacother. 2021 08; 55(8):1025-1036.
-
Walking Volume and Speed Are Inversely Associated With Incidence of Treated Hypertension in Postmenopausal Women. Hypertension. 2020 11; 76(5):1435-1443.
-
Incidence and Management of Glaucoma or Glaucoma Suspect in the First Year After Pediatric Lensectomy. JAMA Ophthalmol. 2020 01 01; 138(1):71-75.